Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...
5don MSN
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...
New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...
8don MSN
In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback